According to the latest data from the Hong Kong Stock Exchange, on January 27, a shareholder of TOUYUN BIOTECH (01332) transferred shares from Mingji Securities to CMB Wing Lung Bank, with a portfolio transfer value of HK$26.82 million, accounting for 9.02% of the holdings. Previously, TOUYUN BIOTECH released its interim results for the six months ended June 30, 2025, revealing that the group generated revenue of HK$36.581 million from sales of goods and services, a decrease of 20.82% year-on-year; profit attributable to company owners was HK$11.243 million, a significant turnaround from a loss of HK$47.969 million in the same period last year; earnings per share stood at 0.4 HK cents.